Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Market-Moving News for August 18th

Author: Benzinga Newsdesk | August 18, 2025 06:45am

NVO: 7% | Novo Nordisk shares are trading higher after the FDA approved Wegovy for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

 

BTAI: 37% | BioXcel Therapeutics Achieves Alignment With FDA On sNDA Package To Expand IGALMI Label For At-Home Outpatient Treatment Of Agitation In Bipolar Disorders Or Schizophrenia

 

CRGO: 8% | Freightos Q2 Adj. EPS $(0.05) Beats $(0.09) Estimate, Sales $7.438M Beat $7.087M Estimate

Posted In: BTAI CRGO NVO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist